CELOX™ PPH Shortlisted for a Prestigious Award!

31^st March 2025

We’re thrilled to announce that CELOX™ PPH has been shortlisted for an award at the Medilink North of England Healthcare Business Awards 2025! The Medilink Healthcare Business Awards honour outstanding innovations and achievements in medical technology, showcasing the exceptional capabilities, expertise, and creativity of life sciences companies across the North...

CELOX™ PPH Receives Czech PPH Guidelines Endorsement!

20^th March 2025

Czech guidelines highlight the importance of CELOX™ PPH in managing PPH We are pleased to announce that CELOX™ PPH has been recognised by Obstetrics Forum.cz Guidelines on Management of Postpartum Haemorrhage (PPH). This endorsement underscores the proven effectiveness and reliability of CELOX™ PPH as a trusted solution in obstetric care....

CELOX™ PPH gains recognition in Poland’s latest PPH guidelines

20^th March 2025

CELOX™ PPH Recognised in Polish PPH Guidelines We’re excited to announce that CELOX™ PPH has been recognised in the Polish Guidelines for Postpartum Haemorrhage (PPH), as featured in Emergencies in Gynaecology and Obstetrics (2023 Edition). Highlighted in Chapter 24 of Volume II, authored by Agnieszka Pięta-Dolińska and Przemysław Oszukowski, CELOX™ PPH is...

Medtrade Wins Scale-Up Entrepreneur of the Year Award 2023

22^nd November 2023

What an extraordinary evening it was at The Allica Bank Great British Entrepreneur Awards held at London’s Grosvenor House on Monday, 20th November! We are thrilled to announce that Medtrade Products was honoured with the prestigious Scale-Up Entrepreneur of the Year 2023 Award, recognising our pioneering CELOX technology. This...

Medtrade awarded Innovation of the Year 2023

25^th October 2023

Fabulous evening at the TheBusinessDesk.com North West Business of the year awards ceremony held in Manchester 18th Oct 2023. Medtrade Products was awarded winner of the Innovation category of the year for their life-saving CELOX technology and recent global introduction of CELOX PPH to address one of the leading causes of maternal...

Medtrade Shortlisted for the 2023 Great British Entrepreneur Awards

21^st June 2023

Medtrade, a Cheshire-based Medical |Device and Bio-Technology company, is excited to announce that they have been shortlisted for the prestigious 2023 Great British Entrepreneur Awards in two separate categories Scale-Up Entrepreneur of the Year and Technology Entrepreneur of the Year categories. This recognition reflects their exceptional entrepreneurial spirit, dedication, and...

From Battlefield to Bedside- CELOX success story- BBC World Series Interview with Medtrade CEO Russ Mably

25^th March 2023

Click Play to hear the extract.

Medtrade partners with Dahlhausen® Medizintechnik to reach maternity units across Germany and Austria

22^nd February 2023

Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help...

CEO Russ Mably on Business Brunch with Des Machin – Cat Radio

7^th July 2022

Russ Mably, our CEO of Medtrade and Celox Medical products, attended an interview on Cat Radio to proudly discuss the highlights of Medtrade and the support provided to the crisis in Ukraine. Medtrade mobilised rapidly reacting to the situation in Ukraine and is manufacturing around the clock to help support...

CPJ and Medtrade to distribute CELOX lifesaving medical supplies in Ukraine

9^th May 2022

New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies,...

MEDTRADE RECEIVES EU MDR CERTIFICATION FOR THE CELOX CE RANGE

17^th March 2022

Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company...

Medtrade awarded innovation grant to develop next generation haemostatic technology

16^th September 2021

Medtrade Products Ltd are proud to announce the successful award of an innovation and research project from the Medical Technology Enterprise Consortium (MTEC NCH – MTEC (mtec-sc.org). Despite fierce competition from numerous different companies, the U.S. Army Medical Material Development Activity (USAMMDA) selected Medtrade Products Ltd to create a product...